Vasooclusive Disorder of the Retinal Vein: Contemporary Pharmacotherapy Therapy in Retinal Vein Occlusion

Retinal vein occlusion as a vasooclusive disorder of the retinal vein is the most common visually disabling disease affecting the retina after diabetic retinopathy, and is a frequent cause of vision loss and even blindness. Although it is more common in the middle-aged and elderly population, no age group is immube to it. The retinal vein occlusion pathogenesis has varied systemic and local implications that make it difficult to elaborate treatment guidelines. The disease entity has long been known, but there is a great deal of confusion regarding its management. Various new therapeutic approaches have been developed in the past few years.The objective of this review is to evaluate the treatments commonly advocated, emphasizing evidence-based ones, in the light of our current scientific knowledge of retinal vein occlusion.